Provided by Tiger Trade Technology Pte. Ltd.

Novavax

9.26
+0.21002.32%
Post-market: 9.280.0200+0.22%19:59 EDT
Volume:4.21M
Turnover:38.42M
Market Cap:1.52B
PE:-6.10
High:9.34
Open:9.18
Low:8.89
Close:9.05
52wk High:11.97
52wk Low:6.20
Shares:164.43M
Float Shares:143.00M
Volume Ratio:0.70
T/O Rate:2.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5181
EPS(LYR):2.58
ROE:-898.20%
ROA:-6.51%
PB:-7.98
PE(LYR):3.59

Loading ...

Novavax Exec Says Plans to Pay Off Pandemic Era Epa Liabilities by Q1 of 2029 - Conf Call

THOMSON REUTERS
·
Aug 06

Novavax Shares up 1.6% Premarket After Co Lifts 2026 Revenue Forecast

THOMSON REUTERS
·
Aug 06

Novavax Q2 2026 earnings: Revenue falls as prior-year payments roll off

TradingKey
·
Aug 06

Earnings Flash (NVAX) Novavax Posts Q2 Net Loss of $0.32 a Share, vs. FactSet Est. of $0.38 Loss

MT Newswires Live
·
Aug 06

Novavax Outlook FY Adjusted Total Revenue USD 235-275 Million

THOMSON REUTERS
·
Aug 06

Novavax Q2 EPS $-0.32 Ibes Estimate $-0.39

THOMSON REUTERS
·
Aug 06

Novavax Outlook 2026 Adj Revenue $235 Mln to $275 Mln vs Ibes Estimate $389.2 Mln

THOMSON REUTERS
·
Aug 06

Novavax: on Track to Advance C. Difficile Vaccine Program into the Clinic as Early as 2027

THOMSON REUTERS
·
Aug 06

Novavax: Manufacturing Technology Transfer to Sanofi for Nuvaxovid Expected to be Completed Mid-2027. Would Trigger $75 Mln Milestone Payment to Co

THOMSON REUTERS
·
Aug 06

Novavax Q2 REV $57 Mln vs Ibes Estimate $52.5 Mln

THOMSON REUTERS
·
Aug 06

Novavax Lifts Annual Revenue Forecast as Licensing Bets Offset Weak Vaccine Demand

Reuters
·
Aug 06

Novavax Outlook 2026 Adj Combined R&D and SG&a Expenses $310 Mln to $340 Mln

THOMSON REUTERS
·
Aug 06

Novavax Q2 FY26 Turns to Net Loss of $53.39 Million; Revenue Drops 76.29% to $56.7 Million

Reuters
·
Aug 06

Novavax Q2 EPS $(0.32) Beats $(0.37) Estimate, Sales $56.698M Beat $52.513M Estimate

Benzinga Earnings
·
Aug 06

Novavax Inc Expected to Post a Loss of 39 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS)

TIPRANKS
·
Aug 04

Novavax Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Aug 04

Novavax Inc. Stock Rises Thursday, Still Underperforms Market

Dow Jones
·
Jul 31

Novavax to Report Q2 2026 Results, Host Conference Call

Reuters
·
Jul 30

Novavax Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 29